Servier shared a post on X:
“For decades, medicine has long treated diseases at the source. In 2025, new technologies take it further, targeting illness from inside the cell with greater precision and fewer side effects.
Thanks to scientific progress, we’re now developing therapies that go straight to the source of disease, deep inside our cells.”
More posts featuring Servier Pharmaceuticals.